Business ❯ Corporate Governance ❯ Investor Relations ❯ Public Companies

Telix Pharmaceuticals

Telix Securities Class Action Draws Flurry of Investor Notices Ahead of Lead-Plaintiff Deadline

Plaintiffs attribute investor losses to SEC and FDA disclosures revealing alleged misstatements.

Multiple Firms File Securities Class Actions Against Telix in Indiana Federal Court Over Prostate Cancer Program Disclosures